Abstract:E3 ubiquitin ligases are very important to regulate antiviral immunity during viral infection. Here, we discovered that Ankyrin repeat and SOCS box-containing protein 3 (ASB3), an E3 ligase, are upregulated in the presence of RNA viruses, particularly Influenza A virus (IAV). Notably, overexpression of ASB3 inhibits type I IFN (IFN-I) responses induced by Sendai virus (SeV) and H9N2, and ablation of ASB3 restores SeV and H9N2 infection-mediated transcription of IFN-β and its downstream interferon-stimulated genes (ISGs). Interestingly, animals lacking ASB3 showed a decreased susceptibility to H9N2 and PR8 infections. Mechanistically, ASB3 interacts with MAVS and directly mediates K48-linked polyubiquitination and degradation of MAVS at K297, thereby inhibiting the phosphorylation levels of TBK1 and IRF3, downregulating downstream antiviral signaling. These findings establish ASB3 as a critical negative regulator in controlling the activation of antiviral signaling and describe a novel function of ASB3 that has not been previously reported. IMPORTANCE IAV is a significant zoonotic pathogen that causes infections of the respiratory system. Hosts have evolved multiple strategies to defend against IAV infection. However, not all host proteins play an active defense role. In this study, we found that the E3 ligase ASB3 regulates antiviral immunity by manipulating MAVS stability. Briefly, overexpression of ASB3 degrades MAVS, thereby promoting viral replication. In contrast, ASB3 deletion restores MAVS expression, upregulating IFN-I responses. Additional research revealed that ASB3 mediates the K48-linked polyubiquitination of MAVS at K297, resulting in ASB3 being degraded via the ubiquitin-proteasome pathway. These findings reveal, for the first time, a novel mechanism by which ASB3 negatively regulates antiviral immunity and provides a potential target for anti-IAV drug development.

E3 Ubiquitin Ligases: The Operators of the Ubiquitin Code That Regulates the RLR and cGAS-STING Pathways

E3 ubiquitin ligases, the powerful modulator of innate antiviral immunity

Lysosomal Control of the Cgas-Sting Signaling.

Role of E3 ubiquitin ligases and deubiquitinating enzymes in SARS-CoV-2 infection

Human E3 ubiquitin ligases: accelerators and brakes for SARS-CoV-2 infection

Regulation of Innate Antiviral Immunity by Protein Ubiquitination

Regulation of SARS-CoV-2 Infection and Antiviral Innate Immunity by Ubiquitination and Ubiquitin-Like Conjugation

The E3 ubiquitin ligase RNF185 facilitates the cGAS-mediated innate immune response

Ubiquitin ligase enzymes and de-ubiquitinating enzymes regulate innate immunity in the TLR, NLR, RLR, and cGAS-STING pathways

The regulation of cGAS-STING signaling by RNA virus-derived components

Post-translational Control of Intracellular Pathogen Sensing Pathways

Multiple E3 ligases act as antiviral factors against SARS-CoV-2 via inducing the ubiquitination and degradation of ORF9b

Progress on Poxvirus E3 Ubiquitin Ligases and Adaptor Proteins

Post-translational regulation of antiviral innate signaling

E3 Ligase HECTD3 Promotes RNA Virus Replication and Virus-Induced Inflammation Via K33-linked Polyubiquitination of PKR

Regulation of cGAS- and RLR-mediated immunity to nucleic acids

Ubiquitin ligases and the immune response.

Regulation of Cellular Antiviral Signaling by Modifications of Ubiquitin and Ubiquitin-like Molecules

The cGAS-STING pathway in viral infections: a promising link between inflammation, oxidative stress and autophagy

E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation

Regulation of RIG-I-like receptor-mediated signaling: interaction between host and viral factors